291 related articles for article (PubMed ID: 3088107)
1. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
[TBL] [Abstract][Full Text] [Related]
2. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
Xiang J; Moyana T; Kalra J; Hamilton T; Qi Y
Mol Biother; 1992 Dec; 4(4):174-83. PubMed ID: 1476671
[TBL] [Abstract][Full Text] [Related]
4. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M
J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
[TBL] [Abstract][Full Text] [Related]
6. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
[TBL] [Abstract][Full Text] [Related]
8. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
9. [Construction, expression and characterization of a murine/human chimeric antibody with specificity for hepatitis B surface antigen].
Li Y; Shearman CW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):318-24. PubMed ID: 2151688
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
Hutzell P; Kashmiri S; Colcher D; Primus FJ; Hand PH; Roselli M; Finch M; Yarranton G; Bodmer M; Whittle N
Cancer Res; 1991 Jan; 51(1):181-9. PubMed ID: 1988082
[TBL] [Abstract][Full Text] [Related]
11. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
[TBL] [Abstract][Full Text] [Related]
12. Cloning of cDNAs coding for heavy- and light-chain variable regions of a murine monoclonal antibody with specificity for human plasma apolipoprotein A-I.
Lee SH; Kim CS; Cho MH
Res Commun Mol Pathol Pharmacol; 1997 Sep; 97(3):263-77. PubMed ID: 9387187
[TBL] [Abstract][Full Text] [Related]
13. Construction of a chimeric antibody with therapeutic potential for cancers which overexpress c-erbB-2.
Liu HL; Parkes DL; Langton BC; Xuan JA; Longhi M; Elliger SS; Chao LA; McGrogan MP; Brandis JW; Shawver LK
Biochem Biophys Res Commun; 1995 Jun; 211(3):792-803. PubMed ID: 7598708
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a human T cell-specific chimeric antibody (CD7) with human constant and mouse variable regions.
Heinrich G; Gram H; Kocher HP; Schreier MH; Ryffel B; Akbar A; Amlot PL; Janossy G
J Immunol; 1989 Dec; 143(11):3589-97. PubMed ID: 2479683
[TBL] [Abstract][Full Text] [Related]
15. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
[TBL] [Abstract][Full Text] [Related]
16. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and chimerisation of CDI 315B monoclonal antibody.
Kopitar-Jerala N; Bestagno M; Fan X; Novak-Despot D; Burrone O; Kos J; Skrk J; Gubensek F
Pflugers Arch; 2000; 439(3 Suppl):R79-80. PubMed ID: 10653149
[TBL] [Abstract][Full Text] [Related]
19. The construction of a mouse/human chimeric antibody against human breast cancer cells.
Meulemans E; Vandevyver C; Volckaert G; Raus J
Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
[No Abstract] [Full Text] [Related]
20. Tumor-specific genetically engineered murine/human chimeric monoclonal antibody.
Brown BA; Davis GL; Saltzgaber-Muller J; Simon P; Ho MK; Shaw PS; Stone BA; Sands H; Moore GP
Cancer Res; 1987 Jul; 47(13):3577-83. PubMed ID: 3555775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
